Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TORCH: Glucose Metabolism in Human Immune Cells
NCT06930976Recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- Oct 2025
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Vanderbilt University Medical Center. Primary endpoint: 13C6-glucose uptake in immune cells at 4 hours. Started Oct 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06930976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06930976.